Stifel Financial
KRTX

Stifel Financial’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Stifel Financial’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,507
Closed -$2.69M – 3454
2023
Q4 		$2.69M Buy
8,507
+701
+9% +$136K ﹤0.01% 1473
2023
Q3 		$1.32M Buy
7,806
+241
+3% +$45.3K ﹤0.01% 1856
2023
Q2 		$1.64M Buy
7,565
+2,387
+46% +$511K ﹤0.01% 1767
2023
Q1 		$941K Buy
5,178
+1,221
+31% +$234K ﹤0.01% 2101
2022
Q4 		$778K Buy
3,957
+991
+33% +$213K ﹤0.01% 2183
2022
Q3 		$667K Sell
2,966
-37
-1% -$7.49K ﹤0.01% 2247
2022
Q2 		$380K Sell
3,003
-243
-7% -$27.9K ﹤0.01% 2621
2022
Q1 		$412K Sell
3,246
-700
-18% -$78.8K ﹤0.01% 2681
2021
Q4 		$517K Buy
3,946
+375
+11% +$48.5K ﹤0.01% 2572
2021
Q3 		$437K Hold
3,571
– – ﹤0.01% 2656
2021
Q2 		$407K Hold
3,571
– – ﹤0.01% 2703
2021
Q1 		$429K Buy
3,571
+1,455
+69% +$165K ﹤0.01% 2576
2020
Q4 		$215K Sell
2,116
-2,515
-54% -$233K ﹤0.01% 2784
2020
Q3 		$358K Sell
4,631
-1,320
-22% -$112K ﹤0.01% 2289
2020
Q2 		$664K Sell
5,951
-103
-2% -$8.96K ﹤0.01% 1832
2020
Q1 		$435K Buy
+6,054
New +$518K ﹤0.01% 1951

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Stifel Financial's KRTX Position: Q1 2024 in Review

Stifel Financial sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 8,507 shares — an estimated $2.69M sold.

Stifel Financial first reported a position in KRTX in Q1 2020 and held it in 16 quarters. The position peaked at $2.69M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Stifel Financial reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Stifel Financial sold 8,507 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.69M.
  • Stifel Financial first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • Stifel Financial's Karuna Therapeutics, Inc. Common Stock position peaked at $2.69M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Stifel Financial's 13F filing for Q1 2024, filed 14 May 2024.